Human leukocyte antigens related to Epstein-Barr virus-associated gastric carcinoma in Japanese patients

被引:14
作者
Koriyama, C
Shinkura, R
Hamasaki, Y
Fujiyoshi, T
Eizuru, Y
Tokunaga, M
机构
[1] Kagoshima Univ, Fac Med, Dept Publ Hlth, Kagoshima 8908520, Japan
[2] Kagoshima City Hosp, Dept Pathol, Kagoshima, Japan
[3] Kagoshima Univ, Fac Med, Dept Virol, Kagoshima 890, Japan
[4] Kagoshima Univ, Fac Med, Ctr Chron Viral Dis, Div Oncogen & Persistent Viruses, Kagoshima 890, Japan
[5] Kodama Hosp, Kagoshima, Japan
关键词
EBV; HLA; stomach neoplasms;
D O I
10.1097/00008469-200102000-00008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To assess the association between specific types of human leukocyte antigen and the risk of Epstein-Barr virus (EBV)-associated gastric carcinoma, serological typing for major histocompatibility complex class I and class LI antigens was performed for 110 EBV-positive and 155 EBV-negative gastric carcinoma cases. In class I analysis, the frequency of B59 in the EBV-positive cases was higher than for the EBV-negative cases (odds ratio (OR) 3.06; 95% confidence interval (CI) 1.02-9.23). For class II antigens, DQ3 and DR9 frequencies in the EBV-positive cases were higher (OR 1.94; 95% CI 1.16-3.24 and OR 1.93; 95% CI 1.11-3.37, respectively), whereas DR11 frequency was lower than found in the EBV-negative cases (OR 0.10; 95% CI 0.01-0.79). After adjusting for multiple comparisons, only DR11 frequency remained significantly lower in the EBV-positive cases (P = 0.04), and the association of DQ3 was marginally significant (P = 0.05). These results suggest that the presence of DR11-restricted cytotoxic T cells (CTLs) related to EBV-associated gastric carcinoma, or a deficiency of DR11 and a high frequency of DQ3 may be genetic markers for a population at greater risk of EBV-associated gastric carcinoma. However, further extensive studies to more cases and DNA typing are needed because our findings in this study are exploratory. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:69 / 75
页数:7
相关论文
共 29 条
[1]   ABERRANT EXPRESSION OF HLA CLASS-I ANTIGENS IN BURKITT-LYMPHOMA CELLS [J].
ANDERSSON, ML ;
STAM, NJ ;
KLEIN, G ;
PLOEGH, HL ;
MASUCCI, MG .
INTERNATIONAL JOURNAL OF CANCER, 1991, 47 (04) :544-550
[2]  
BEGG CB, 1994, CANCER EPIDEM BIOMAR, V3, P173
[3]   HLA AND NASOPHARYNGEAL CARCINOMA IN CHINESE - A FURTHER STUDY [J].
CHAN, SH ;
DAY, NE ;
KUNARATNAM, N ;
CHIA, KB ;
SIMONS, MJ .
INTERNATIONAL JOURNAL OF CANCER, 1983, 32 (02) :171-176
[4]  
Chang K L, 1992, Diagn Mol Pathol, V1, P246, DOI 10.1097/00019606-199203000-00037
[5]  
Colton T, 1974, STAT MED
[6]  
Galetsky SA, 1997, INT J CANCER, V73, P786, DOI 10.1002/(SICI)1097-0215(19971210)73:6&lt
[7]  
786::AID-IJC2&gt
[8]  
3.0.CO
[9]  
2-Z
[10]  
Herrera-Goepfert R, 1999, MODERN PATHOL, V12, P873